This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast on May 2, 2024 In the wake of recent bipartisan policy wins in…
As we mark Earth Day, we have just experienced the hottest March on record. But…
What happens when music therapists and neuroscientists team up? Patients win, says Dr. Francis Collins.…
Originally published April 9, 2024 She’s received worldwide praise for singing at the Super Bowl,…
Originally published April 4, 2024 It’s about seven months to election day and our regular…
Originally published March 28, 2024 Medicare just announced that it will pay for weight loss…